Gilead Sciences (NASDAQ: GILD) insider plans another 3,000-share sale
Rhea-AI Filing Summary
Gilead Sciences insider Andrew Dickinson filed a notice to sell 3,000 shares of common stock of GILD through Morgan Stanley Smith Barney LLC, with an aggregate market value of $415,080.00, expected on August 17, 2026. The shares were acquired as Performance Shares on January 31, 2024. Dickinson previously sold 3,000 shares on June 15, 2026 for $376,200.00 and 3,000 shares on July 15, 2026 for $389,776.80.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 3,000 shares
Aggregate market value: $415,080.00
Sale on 06/15/2026: 3,000 shares for $376,200.00
+3 more
6 metrics
Planned shares to be sold
3,000 shares
Common stock proposed for sale on 08/17/2026
Aggregate market value
$415,080.00
Market value of 3,000 shares in proposed 08/17/2026 sale
Sale on 06/15/2026
3,000 shares for $376,200.00
Common stock sold during past three months
Sale on 07/15/2026
3,000 shares for $389,776.80
Common stock sold during past three months
Acquisition date of shares
01/31/2024
Performance Shares from issuer to be sold under Form 144
Planned sale date
08/17/2026
Expected date of Form 144 sale on NASDAQ
Key Terms
Form 144, Performance Shares, aggregate market value
3 terms
Form 144 regulatory
"144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
aggregate market value financial
"3000 | 415080.00 | 1239955155 | 08/17/2026"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
FAQ
What does Gilead Sciences’ (GILD) latest Form 144 filing disclose?
The filing discloses that Andrew Dickinson plans to sell 3,000 shares of Gilead common stock, with an aggregate market value of $415,080.00, through Morgan Stanley Smith Barney LLC on August 17, 2026.
What recent GILD stock sales has Andrew Dickinson reported in the past three months?
He reported selling 3,000 shares of Gilead common stock on June 15, 2026 for $376,200.00 and another 3,000 shares on July 15, 2026 for $389,776.80, as listed in the three-month sales section.
AI-generated analysis. How Rhea-AI works. Not financial advice.